Anti-phospholipase A2 receptor antibodies in membranous nephropathy.
作者信息
Lee Sangho
机构信息
Department of Nephrology, College of Medicine, Kyung Hee University, Seoul, Korea.
Multi-Omics Research Institute, Kyung Hee University, Seoul, Korea.
出版信息
Kidney Res Clin Pract. 2018 Sep;37(3):181-182. doi: 10.23876/j.krcp.2018.37.3.181. Epub 2018 Sep 30.
Abstract
摘要
相似文献
1
Anti-phospholipase A2 receptor antibodies in membranous nephropathy.膜性肾病中的抗磷脂酶A2受体抗体
Kidney Res Clin Pract. 2018 Sep;37(3):181-182. doi: 10.23876/j.krcp.2018.37.3.181. Epub 2018 Sep 30.
2
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies.评价利妥昔单抗治疗膜性肾病的疗效：11 项研究的系统评价和荟萃分析。
Nephrol Ther. 2022 Apr;18(2):104-112. doi: 10.1016/j.nephro.2021.10.002. Epub 2022 Jan 21.
3
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.原发性膜性肾病患者的M型磷脂酶A2受体自身抗体与肾功能
Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29.
4
Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy.磷脂酶 A2 受体抗体 IgG4 亚类提高特发性膜性肾病诊断的敏感性和特异性。
Kidney Blood Press Res. 2019;44(4):848-857. doi: 10.1159/000500456. Epub 2019 Jun 26.
5
Clinical significance of Mtype phospholipase A2 receptor and thrombospondin Type 1 domaincontaining 7A in primary membranous nephropathy.M型磷脂酶A2受体和含血小板反应蛋白1结构域7A在原发性膜性肾病中的临床意义
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jun 28;45(6):693-700. doi: 10.11817/j.issn.1672-7347.2020.190109.
6
Very early recurrence of anti-Phospholipase A2 receptor-positive membranous nephropathy after transplantation.移植后抗磷脂酶 A2 受体阳性膜性肾病的早期复发。
Am J Transplant. 2012 Jun;12(6):1637-42. doi: 10.1111/j.1600-6143.2011.03957.x. Epub 2012 Mar 5.
7
Anti-Phospholipase A2 Receptor Antibodies in Biopsy-Proven Idiopathic Membranous Nephropathy: A Report from the Pakistani Population.抗磷脂酶 A2 受体抗体在经活检证实的特发性膜性肾病中的作用：来自巴基斯坦人群的报告。
J Coll Physicians Surg Pak. 2022 Jul;32(7):950-952. doi: 10.29271/jcpsp.2022.07.950.
8
Rapidly Progressing Primary Membranous Nephropathy in a Hispanic Male With Elevated Levels of Anti-phospholipase A2 Receptor Antibodies.一名西班牙裔男性患有抗磷脂酶A2受体抗体水平升高的快速进展性原发性膜性肾病。
Cureus. 2021 Jun 11;13(6):e15594. doi: 10.7759/cureus.15594. eCollection 2021 Jun.
9
Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experience.原发性膜性肾病患者血清抗M型磷脂酶A2受体抗体的患病率：单中心经验
Indian J Nephrol. 2016 Jul-Aug;26(4):257-61. doi: 10.4103/0971-4065.160334.
10
Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.中国特发性膜性肾病患者血栓反应蛋白型 I 域包含蛋白 7A 的循环抗体。
Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1642-1651. doi: 10.2215/CJN.01460217. Epub 2017 Aug 11.
引用本文的文献
1
Retrospective analysis of polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria.回顾性分析聚糖肽联合血管紧张素受体阻滞剂治疗伴有亚肾病范围蛋白尿的原发性膜性肾病。
Ren Fail. 2021 Dec;43(1):729-736. doi: 10.1080/0886022X.2021.1918555.
2
Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.特发性膜性肾病患者血清抗磷脂酶 A2 受体抗体与肾小球抗原。
Biomed Res Int. 2020 May 8;2020:1693710. doi: 10.1155/2020/1693710. eCollection 2020.
本文引用的文献
1
Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy.抗磷脂酶A2受体抗体作为原发性膜性肾病患者的预后标志物
Kidney Res Clin Pract. 2018 Sep;37(3):248-256. doi: 10.23876/j.krcp.2018.37.3.248. Epub 2018 Sep 30.
2
Treatment of membranous nephropathy: time for a paradigm shift.膜性肾病的治疗：范式转变的时刻。
Nat Rev Nephrol. 2017 Sep;13(9):563-579. doi: 10.1038/nrneph.2017.92. Epub 2017 Jul 3.
3
Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.通过检测抗PLA2R抗体并结合检测膜性肾病中PLA2R抗原所发现的PLA2R自身免疫的预后价值：一项为期14年的单中心研究
PLoS One. 2017 Mar 3;12(3):e0173201. doi: 10.1371/journal.pone.0173201. eCollection 2017.
4
A Proposal for a Serology-Based Approach to Membranous Nephropathy.一种基于血清学方法诊断膜性肾病的建议。
J Am Soc Nephrol. 2017 Feb;28(2):421-430. doi: 10.1681/ASN.2016070776. Epub 2016 Oct 24.
5
Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy.血清抗磷脂酶A2受体抗体可预测特发性膜性肾病的治疗结果。
Am J Nephrol. 2016;43(2):129-40. doi: 10.1159/000445361. Epub 2016 Apr 9.
6
Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy.抗磷脂酶A2受体抗体作为特发性膜性肾病的预后指标
Am J Nephrol. 2015;42(3):250-7. doi: 10.1159/000440983. Epub 2015 Oct 20.
7
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.特发性膜性肾病中的含血小板反应蛋白1型结构域7A
N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13.
8
The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey.特发性膜性肾病的发病机制：50 年的探索历程。
Am J Kidney Dis. 2010 Jul;56(1):157-67. doi: 10.1053/j.ajkd.2010.01.008. Epub 2010 Apr 8.
9
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
Zotero 插件